Cancer Therapy: New Trends
Editat de Peter Bannaschen Limba Engleză Paperback – 27 iul 1989
Preț: 702.35 lei
Preț vechi: 739.32 lei
-5% Nou
Puncte Express: 1054
Preț estimativ în valută:
134.42€ • 139.62$ • 111.65£
134.42€ • 139.62$ • 111.65£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540510345
ISBN-10: 3540510346
Pagini: 276
Ilustrații: XVI, 256 p. 17 illus.
Dimensiuni: 170 x 242 x 14 mm
Greutate: 0.45 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540510346
Pagini: 276
Ilustrații: XVI, 256 p. 17 illus.
Dimensiuni: 170 x 242 x 14 mm
Greutate: 0.45 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Session 1 Surgery.- Advances in Surgical Oncology.- Photodynamic Laser Therapy of Photosensitized Tumors.- Radiosurgery with a Linear Accelerator: Method, Indications and Preliminary Results.- Summary of Discussion: Session 1.- Session 2 Radiation.- New Trends in Radiation Therapy: Fast Neutrons and New Particles.- Altered Fractionation in Radiotherapy.- New Trends in Computer-Assisted Radiotherap with Conventional Radiation.- Intraoperative Radiation Therapy for Glioblastoma - Indications and Treatment Results.- Summary of Discussion: Session 2.- Session 3 Hyperthermia.- Hyperthermia in Tumor Treatment.- Regional Hyperthermia and Systemic Chemotherapy.- Summary of Discussion: Session 3.- Session 4 Chemotherapy.- New Trends in Chemotherapy of Tumors.- New Antineoplastic Agents.- Enzyme-Pattern-Targeted Chemotherapy.- Nuclear Components and Plasma Membrane as Targets of Chemotherapeutic Agents.- Drug Resistant Cells as Targets for Chemotherapeutic Agents.- Summary of Discussion: Session 4.- Session 5 Biological Response.- Biological Response Modifiers: Mechanisms of Action.- Biological Response Modifiers: Clinical Aspects.- Predictive Assays for the Individualization of Tumor Therapy.- Molecular Genetic Changes as Indicators of Therapeutic Effectiveness.- Summary of Discussion: Session 5.- Session 6 Bone Marrow Transplantation.- Allogeneic Marrow Transplantation in Acute Leukemia and Chronic Myelogenous Leukemia - Johns Hopkins Experience.- Autologous Bone Marrow Transplantation.- Summary of Discussion: Session 6.- Session 7 Antibody Guided Therapy.- Predictive Pharmacology of Monoclonal Antibodies.- A New Approach in the Treatment of Advanced Ovarian Cancer and Brain Glioma Using Radiolabelled Monoclonal Antibodies.- Ricin A Chain - Monoclonal Antibody 791T/36 Immunotoxin for Treatment of Colorectal and Ovarian Cancer.- Experimental Approaches to Tumor Therapy with Monoclonal Antibodies.- Summary of Discussion: Session 7.- Session 8 Cell Differentiation and Growth.- Induced Differentiation of Transformed Cells by Polar Compounds: From Molecular Studies to Clinical Trials.- Hematopoietic Cytokines in Cancer Therapy: Concepts and First Clinical Observations.- Summary of Discussion: Session 8.